Dominik Niopek
Professor
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Dominik Niopek is a Professor at Heidelberg University in Germany. His research focuses on optogenetics, CRISPR technology, and protein dynamics, as evidenced by his recent publications. He has contributed to advancements in optogenetic tools and the characterization of anti-CRISPR proteins, along with investigations into protein allostery and viral interactions with host cells.
Articles (10)
Year:
2025
Year:
2024
Year:
2023
Virus-host interactions can reveal potentially effective and selective therapeutic targets for treating infection. Here, we performed an integrated analysis of the dynamics of virus replication and the host cell transcriptional response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection using human Caco-2 colon cancer cells as a model. Time-resolved RNA sequencing revealed that, upon infection, cells immediately transcriptionally activated genes associated with inflammatory pathways that mediate the antiviral response, which was followed by an increase in the expression of genes involved in ribosome and mitochondria function, thus suggesting rapid alterations in protein production and cellular energy supply. At later stages, between 24 and 48 hours after infection, the expression of genes involved in metabolic processes—in particular, those related to xenobiotic metabolism—was decreased. Mathematical modeling incorporating SARS-CoV-2 replication suggested that SARS-CoV-2 proteins inhibited the host antiviral response and that virus transcripts exceeded the translation capacity of the host cells. Targeting kinase-dependent pathways that exhibited increases in transcription in host cells was as effective as a virus-targeted inhibitor at repressing viral replication. Our findings in this model system delineate a sequence of SARS-CoV-2 virus-host interactions that may facilitate the identification of druggable host pathways to suppress infection.
Year:
2023
Year:
2021
Year:
2020
Year:
2020
Year:
2020
Year:
2020
Year:
2020
Collaborators (4)
Stefan M. Kallenberger
-
Steeve Boulant
Assistant Professor
University of Florida
Julius Upmeier zu Belzen
Berlin Institute of Health at Charité - Universitätsmedizin Berlin
Megan Stanifer
Assistant Professor
University of Florida
Make your next move.
Prepare your application
Review drafts before you send them.